ResMed | RMD - 销售成本

金融业

USD

USD 8.78B

现金及等价物

USD 1.66B

USD 551.67M

USD 4.06B

USD 1.35B

USD 847.72M

股息收益率

1.04

USD 505.67M

USD 547.48M

10.6K

EPS每股收益

USD 2.86

股本和储备

USD 6.49B

USD 890.98M

债务利息支出

USD 8.79M

USD 59K

USD 404.17M

USD 30.94B

USD 398.73M

USD 925.74M

USD 505.67M

普通股股本

USD 190.83M

21.21

USD 496.15M

USD 1.4B

销售和管理费用

USD 279.8M

USD 911.88M

贸易债权人

USD 273.3M

应收帐款人

USD 998.84M

	销售成本	更改		日
Ansell	USD 605.3M		351.2M	2025-12
Artivion	USD 42.85M		3.86M	2025-12
AtriCure	USD 31.94M		3.22M	2026-03
Baxter International	USD 1.81B		587M	2026-03
Cochlear	AUD 319.2M		160.35M	2025-12
Cooper Companies	USD 376.8M		87.4M	2025-12
CSL	USD 3.87B		2.08B	2025-12
Dexcom	USD 441.6M		25.3M	2026-03
Edwards Lifesciences	USD 362.6M		19.6M	2026-03
Fisher Paykel Healthcare	NZD 402.8M		15.2M	2025-12
Globus Medical	USD 263.59M		26.88M	2026-03
Haemonetics	USD 136.58M		4.01M	2025-12
Idexx Laboratories	USD 418.08M		14.38M	2026-03
Inogen	USD 39.59M		1.27M	2024-09
Insulet	USD 232.7M		17.5M	2026-03
Integra LifeSciences	USD 178.71M		14.73M	2026-03
Intuitive Surgical	USD 940.3M		21.6M	2026-03
Masimo	USD 152.8M		12.4M	2026-03
Medtronic	USD 3.61B		83M	2025-12
Philips	EUR 2.14B		669M	2026-03
Ramsay Health Care	AUD 3.05B		78.7M	2025-12
ResMed	USD 551.67M		4.17M	2026-03
Sigma Healthcare	AUD 1.55B		165.16M	2024-12
Sonic Healthcare	AUD 751.66M		801.13M	2024-12
Steris	USD 891.3M		50.6M	2026-03
Teleflex	USD 240.84M		20.7M	2026-03
Thermo Fisher Scientific	USD 6.96B		620M	2026-03